Application

Anti-BCRP1 Antibody, clone 5D3, Cy3 conjugate is an antibody against BCRP1 for use in ICC.

General description

Breast cancer resistance protein (BCRP1) is a member of the ATP-binding cassette superfamily of drug transporters thought to be involved in multi-drug resistance in human neoplastic disease. ABCG2 is expressed in drug-resistant breast, colon and gastric cancer and fibrosarcoma cancer cell lines and in blast cells from patients with acute myeloid leukemia (AML). Normal tissues that express the ABCG2 protein include placental syncytiothrophoblasts, mammary ducts and lobules, epithelium in the large intestine and colon, venous and capillary epithelium and bile canalicular membrane of the liver. Several studies indicate that ABCG2 is also expressed in stem cells of different tissues and may be useful as a stem cell marker.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Quality

Evaluated by Immunocytochemistry in A431 Human epidermal carcinoma cells. Immunocytochemsitry Analysis: A 1:50 dilution of this antibody detected BCRP1 in A431 Human epidermal carcinoma cells.

Target description

72 kDa calculated